BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19349319)

  • 61. Left ventricular filling and diastolic myocardial deformation in chronic primary mitral regurgitation.
    Borg AN; Harrison JL; Argyle RA; Pearce KA; Beynon R; Ray SG
    Eur J Echocardiogr; 2010 Jul; 11(6):523-9. PubMed ID: 20185526
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Left ventricular remodeling in preclinical experimental mitral regurgitation of dogs.
    Dillon AR; Dell'Italia LJ; Tillson M; Killingsworth C; Denney T; Hathcock J; Botzman L
    J Vet Cardiol; 2012 Mar; 14(1):73-92. PubMed ID: 22386719
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty.
    Capoulade R; Zeng X; Overbey JR; Ailawadi G; Alexander JH; Ascheim D; Bowdish M; Gelijns AC; Grayburn P; Kron IL; Levine RA; Mack MJ; Melnitchouk S; Michler RE; Mullen JC; O'Gara P; Parides MK; Smith P; Voisine P; Hung J;
    Circulation; 2016 Oct; 134(17):1247-1256. PubMed ID: 27777294
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Carvedilol may alleviate late cardiac remodelling following surgical ventricular restoration.
    Yoshikawa E; Marui A; Tsukashita M; Nishina T; Wang J; Muranaka H; Ikeda T; Komeda M
    Eur J Cardiothorac Surg; 2010 Feb; 37(2):362-7. PubMed ID: 19692266
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice.
    Chiao YA; Ramirez TA; Zamilpa R; Okoronkwo SM; Dai Q; Zhang J; Jin YF; Lindsey ML
    Cardiovasc Res; 2012 Dec; 96(3):444-55. PubMed ID: 22918978
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt-Sensitive Hypertension.
    Zhang Y; Wei W; Shilova V; Petrashevskaya NN; Zernetkina VI; Grigorova YN; Marshall CA; Fenner RC; Lehrmann E; Wood WH; Becker KG; Lakatta EG; Bagrov AY; Fedorova OV
    J Am Heart Assoc; 2019 Oct; 8(20):e012138. PubMed ID: 31576777
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Changes in systemic sympathetic nervous system activity after mitral valve surgery and their relationship to changes in left ventricular size and systolic performance in patients with mitral regurgitation.
    Mehta RH; Supiano MA; Grossman PM; Oral H; Montgomery DG; Briesmiester KA; Smith MJ; Starling MR
    Am Heart J; 2004 Apr; 147(4):729-35. PubMed ID: 15077091
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Should mild-to-moderate and moderate ischemic mitral regurgitation be corrected in patients with impaired left ventricular function undergoing simultaneous coronary revascularization?
    Prifti E; Bonacchi M; Frati G; Giunti IG; Leacche M; Proietti P; Babatasi G; Sani G
    J Card Surg; 2001; 16(6):473-83. PubMed ID: 11925028
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Decorin and biglycan expression is differentially altered in several muscular dystrophies.
    Zanotti S; Negri T; Cappelletti C; Bernasconi P; Canioni E; Di Blasi C; Pegoraro E; Angelini C; Ciscato P; Prelle A; Mantegazza R; Morandi L; Mora M
    Brain; 2005 Nov; 128(Pt 11):2546-55. PubMed ID: 16183658
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Disruption of desmin-mitochondrial architecture in patients with regurgitant mitral valves and preserved ventricular function.
    Ahmed MI; Guichard JL; Soorappan RN; Ahmad S; Mariappan N; Litovsky S; Gupta H; Lloyd SG; Denney TS; Powell PC; Aban I; Collawn J; Davies JE; McGiffin DC; Dell'Italia LJ
    J Thorac Cardiovasc Surg; 2016 Oct; 152(4):1059-1070.e2. PubMed ID: 27464577
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts.
    Mohan RR; Gupta R; Mehan MK; Cowden JW; Sinha S
    Exp Eye Res; 2010 Aug; 91(2):238-45. PubMed ID: 20546727
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased oxidative stress and cardiomyocyte myofibrillar degeneration in patients with chronic isolated mitral regurgitation and ejection fraction >60%.
    Ahmed MI; Gladden JD; Litovsky SH; Lloyd SG; Gupta H; Inusah S; Denney T; Powell P; McGiffin DC; Dell'Italia LJ
    J Am Coll Cardiol; 2010 Feb; 55(7):671-9. PubMed ID: 20170794
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Regional myocardial strain before and after mitral valve repair for severe mitral regurgitation.
    Mankad R; McCreery CJ; Rogers WJ; Weichmann RJ; Savage EB; Reichek N; Kramer CM
    J Cardiovasc Magn Reson; 2001; 3(3):257-66. PubMed ID: 11816622
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High transforming growth factor-beta and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection.
    Eikmans M; Sijpkens YW; Baelde HJ; de Heer E; Paul LC; Bruijn JA
    Transplantation; 2002 Feb; 73(4):573-9. PubMed ID: 11889433
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support.
    Felkin LE; Lara-Pezzi E; George R; Yacoub MH; Birks EJ; Barton PJ
    J Heart Lung Transplant; 2009 Feb; 28(2):117-22. PubMed ID: 19201335
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term echocardiographic changes in left ventricular size and function following surgery for severe mitral regurgitation.
    Ghayal P; Haider A; Aronow WS; Goldberg Y; Bello R; Garcia MJ; Spevack DM
    Med Sci Monit; 2012 Apr; 18(4):CR209-14. PubMed ID: 22460092
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5.
    Engebretsen KV; Skårdal K; Bjørnstad S; Marstein HS; Skrbic B; Sjaastad I; Christensen G; Bjørnstad JL; Tønnessen T
    J Mol Cell Cardiol; 2014 Nov; 76():148-57. PubMed ID: 25169971
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
    Hulin A; Moore V; James JM; Yutzey KE
    Cardiovasc Res; 2017 Jan; 113(1):40-51. PubMed ID: 28069701
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Difference in the diastolic left ventricular wall motion velocities between aortic and mitral regurgitation by pulsed tissue Doppler imaging.
    Abe M; Oki T; Tabata T; Iuchi A; Ito S
    J Am Soc Echocardiogr; 1999 Jan; 12(1):15-21. PubMed ID: 9882774
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Beta1-adrenergic receptor blockade attenuates angiotensin II-mediated catecholamine release into the cardiac interstitium in mitral regurgitation.
    Tallaj J; Wei CC; Hankes GH; Holland M; Rynders P; Dillon AR; Ardell JL; Armour JA; Lucchesi PA; Dell'Italia LJ
    Circulation; 2003 Jul; 108(2):225-30. PubMed ID: 12847066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.